Guardant Health Appoints Oncology Expert to Board of Directors
Express News | DR. Manuel Hidalgo Medina Joins Guardant Health Board of Directors
Guardant Health Is Maintained at Buy by B of A Securities
Guardant Health Is Maintained at Buy by B of A
BofA Securities Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $40
BofA Securities analyst Michael Ryskin maintains $Guardant Health(GH.US)$ with a buy rating, and adjusts the target price from $28 to $40.According to TipRanks data, the analyst has a success rate
Express News | Guardant Health Inc : BofA Global Research Raises Price Objective to $40 From $28
Express News | Guardant Health Inc : Bernstein Raises Target Price to $37 From $33
Assessing Guardant Health: Insights From 7 Financial Analysts
In the latest quarter, 7 analysts provided ratings for Guardant Health (NASDAQ:GH), showcasing a mix of bullish and bearish perspectives.The table below summarizes their recent ratings, showcasing
Express News | Goldman Sachs Maintains Buy on Guardant Health, Raises Price Target to $32
Express News | Guardant Health Inc : TD Cowen Raises Target Price to $41 From $37
Express News | Guardant Health Inc : TD Cowen Raises Target Price to $42 From $37
Is Guardant Health (NASDAQ:GH) Using Too Much Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' When we
Top Premarket Gainers
African Agriculture (AAGR) shares surged nearly 72% in recent Friday premarket activity, shaving Thursday's 3% loss. Cosmos Health (COSM) stock was almost 59% higher after the company said Thursday it
Express News | Guardant Health Shares up 3.1% Premarket After Guggenheim Raises to Buy From Neutral
Guggenheim Initiates Guardant Health(GH.US) With Buy Rating, Announces Target Price $36
Guggenheim analyst Subbu Nambi initiates coverage on $Guardant Health(GH.US)$ with a buy rating, and sets the target price at $36.According to TipRanks data, the analyst has a success rate of 42.9% an
Express News | Guardant Health Inc : Guggenheim Raises to Buy From Neutral
American Cancer Society Projects Over 2 Million New Cases in 2024: Biotech Innovations Respond
USA News Group News Commentary – According to the American Cancer Society, 2024 will be the first year the USA expects to have more than 2 million...
Guardant Health (GH) Now Trades Above Golden Cross: Time to Buy?
Even After Rising 7.4% This Past Week, Guardant Health (NASDAQ:GH) Shareholders Are Still Down 74% Over the Past Three Years
United States Liquid Biopsy Market Forecast to 2031: Company Profiles, Recent Developments and Major Deals - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "United States Liquid Biopsy Market (by Circulating Biomarker, Product, Application, Cancer Types, Non-Cancer Application, End User, Clinical Application, Sample Type), In
Guardant Health(GH.US) Director Sells US$2,787 in Common Stock
$Guardant Health(GH.US)$ Director Joyce Meghan V. sold 100 shares of common stock on Jun 4, 2024 at an average price of $27.87 for a total value of $2,787.Source: Announcement What is statement of cha